Dergiler / Gazi University Journal of Science / 2017 / Cilt: 30 - Sayı: 1

Synthesis, Crystal Structure, Spectroscopic and Density Functional Modelling Studies of The 2-Isopropylbenzimidazolium Tetrachloroplatinate(II) Monohydrate

Sayfa
139–159
Yayın Tarihi
2017-03-14
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There exists a good correlation between experimental and theoretical data for the complex.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Synthesis, crystallographic characterization, spectroscopic and density functional modelling studies of the 2-isopropylbenzimidazolium tetrachloroplatinate monohydrate (C10H13N2)2.[PtCl4].H2O have been reported.
📊
Temel Bulgular & Veri:The compound is comprised of 2-isopropylbenzimidazole (Hipb)+: (C10H13N2)+ and [PtCl4]2- ions, respectively, linked by intermolecular hydrogen bonds N…Cl [3.249(4) from 3.660(7) Å], C…Cl [range from 3.553(7) to 3.895(7) Å] and O atom of anon-coordinating water molecule in the crystal structure N…O [2.728(8) Å], O…Cl [range from 3.234(6) to 3.451(7) Å], C…O [range from 3.350(7) to 3.545(1) Å] for the investigated compound.
💡
Sonuç & Katkı:There exists a good correlation between experimental and theoretical data for the complex.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Crystal structure · platinate salts · benzimidazole

Abstract

Synthesis, crystallographic characterization, spectroscopic and density functional modelling studies of the 2-isopropylbenzimidazolium tetrachloroplatinate monohydrate (C10H13N2)2.[PtCl4].H2O have been reported. The molecular structure of the compound was determined by single-crystal X-ray diffraction analysis. In the compound, the Pt atoms reside at a center of inversion. The compound is comprised of 2-isopropylbenzimidazole (Hipb)+: (C10H13N2)+ and [PtCl4]2- ions, respectively, linked by intermolecular hydrogen bonds N…Cl [3.249(4) from 3.660(7) Å], C…Cl [range from 3.553(7) to 3.895(7) Å] and O atom of anon-coordinating water molecule in the crystal structure N…O [2.728(8) Å], O…Cl [range from 3.234(6) to 3.451(7) Å], C…O [range from 3.350(7) to 3.545(1) Å] for the investigated compound. The molecular structure obtained from X-ray single-crystal analysis of the investigated compound in the ground state has been compared using Hartree-Fock (HF) and density functional theory (DFT) with the functionals B3LYP and PBE1PBE using the LANL2DZ basis set. The experimental (spectroscopic) and calculated vibrational frequencies (using DFT) of the title compound have been compared. There exists a good correlation between experimental and theoretical data for the complex.

🔖

Bu Makaleye Atıf Yap

GOZELLE, M., ZEYREK, C. T., ÜNVER, H., DİLEK, N., GÜMÜŞ, F. (2017). Synthesis, Crystal Structure, Spectroscopic and Density Functional Modelling Studies of The 2-Isopropylbenzimidazolium Tetrachloroplatinate(II) Monohydrate. Gazi University Journal of Science, Cilt: 30 - Sayı: 1, 139–159. https://ajindex.com/articles/254799

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Denny, W.A., Rewcastle, G.W. and Baguley, B.C., “Potential antitumor agents; structure-activity-relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of minimal DNA-intercalating agents which may not act via topoisomerase-II”, J. Med. Chem., 33(2): 814-819, (1990).
  2. Gravatt, G.L., Baguley, B.C., Wilson, W.R. and Denny, W.A., “Na-directed alkylating-agents; synthesis and antitumor-activity of DNA minor groove-targeted aniline mustard analogs of pibenzimol (Hoechst-33258)”, J. Med. Chem., 37(25): 4338-4345, (1994).
  3. Kim, J.S., Gatto, B., Yu, C., Liu, A., Liu, L.F. and LaVoie, E.J., “Substituted 2,5'-bi-1H-benzimidazoles: Topoisomerase I inhibition and cytotoxicity”, J. Med. Chem., 39(4):992-998, (1996)
  4. Horton, D.A., Bourne, G.T. and Smythe, M.L., “The combinatorial synthesis of bicyclic privileged structures or privileged substructures”, Chem. Rev., 103(3): 893-930, (2003).
  5. Bradshaw, T.D., Wrigley, S., Shi, D.F., Schultz, R.J., Paull, K.D. and Stevens, M.F.G., “2-(4-aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity”, Brit. J. Cancer., 77(5): 745-752, (1998).
  6. Payne, J.E., Bonnefous, C., Symons, K.T., Nquyen, P.M., Sablad, M., Rozenkrants, N., Zhang, Y., Wang, L., Wang, L., Yazdani, N., Shiau, A.K., Noble, S.A., Rix, P., Rao, T.S., Hassiq, C.A. and Smith, N.D., “Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-(2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) Part 2: Identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models”, J. Med. Chem., 53(21): 7739-7755, (2010).
  7. Roth, T., Morningstar, M.L., Boyer, P.L., Hughes, S.H., Buckheit, R.W. and Michejda, C.J., “Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-aryl-substituted benzimidazoles”, J. Med. Chem., 40(26): 4199-4207, (1997).
  8. Galal, S.A., Hegab, K.H., Kassab, A.S., Rodriguez, M. L., Kerwin, S.M., El-Khamry, A.A. and El Diwani, H.I., “New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity”, Eur. J. Med. Chem., 44(4): 1500-1508, (2009).
  9. Wang, X.L., Hou, L.L., Zhang, J.W., Gong, C.H. and Liu, G.C., “Bis(benzimidazole)-based ligands-directed the various dimensionality of metal-organic complexes based on carboxylates co-ligands: Syntheses, structures and p